India markets close in 3 hours 34 minutes

Biocon Limited (BIOCON.NS)

NSE - NSE Real Time Price. Currency in INR
Add to watchlist
403.00-14.20 (-3.40%)
As of 11:56AM IST. Market open.

Biocon Limited

20th KM, Hosur Road
Electronics City
Bengaluru 560100
India
91 80 2808 2808
http://www.biocon.com

Sector(s)Healthcare
IndustryBiotechnology
Full-time employees12,609

Key executives

NameTitlePayExercisedYear born
Ms. Kiran Mazumdar-Shaw B.Sc., B.Sc (Hons)Founder & Exec. Chairperson39.25MN/A1953
Mr. Siddharth MittalMD, CEO & Director49.32MN/A1978
Mr. Mayank VermaCompany Sec. & Compliance Officer5.75MN/AN/A
Mr. Anupam JindalChief Financial OfficerN/AN/A1976
Mr. Indranil SenVP of Fin. & AccountsN/AN/AN/A
Mr. Saurabh PaliwalHead of Investor RelationsN/AN/AN/A
Mr. Amitava SahaPres of HRN/AN/A1970
Mr. Sandeep Rao M.Sc., PGDMSr. VPN/AN/A1973
Mr. B. S. V. PrasadChief Operating Officer of Biocon Generics & APIsN/AN/A1967
Mr. Nehal VoraCommercial Head of Biocon Global APIs & Sr. VPN/AN/A1976
Amounts are as of 31 December 2020, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in INR.

Description

Biocon Limited, a biopharmaceutical company, manufactures pharmaceuticals, and medicinal chemical and botanical products. The company operates through Small Molecules, Biologics, Branded Formulations, and Research Services segments. It focuses in the areas of diabetes, oncology, immunology, dermatology, ophthalmology, neurology, rheumatology, and inflammatory diseases. The company provides biosimilars comprising recombinant human insulin, insulin glargine, biosimilar trastuzumab, and other biopharmaceuticals; small molecules, such as active pharmaceutical ingredients and generic formulations; and branded formulation products under the Insugen, Basalog, BIOMAb EGFR, CANMAb, and ALZUMAb brands. It is also involved in the integrated discovery, development, and manufacturing services for small and large molecules, antibody-drug conjugates, and oligonucleotides. The company serves customers in approximately 120 countries. Biocon Limited was founded in 1978 and is headquartered in Bengaluru, India.

Corporate governance

Biocon Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.